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a-Lipoic Acid Is Ineffective as a Topical Antioxidant
for Photoprotection of Skin1
To the Editor:
a-lipoic acid is synthesized in mitochondria of cells (Mori-
kawa et al, 2001) and covalently attached through lysyl
residues to a-keto acid dehydrogenase complexes (Bie-
wenga et al, 1997). The attached a-lipoic acid is a cofactor
for the enzyme and together with dihydrolipoic acid, its re-
duction derivative, serve as a redox couple carrying elec-
trons from the substrate of the enzyme to NADþ . Despite
the fact that there is little or no free a-lipoic acid normally in
tissues (Hermann et al, 1996), a-lipoic acid has been pro-
posed as an antioxidant for topical application to skin to
protect the skin against ultraviolet photodamage including
skin cancer and photoaging changes (Podda et al, 2001).
We have previously studied topical combination vitamin C
(L-ascorbic acid) and vitamin E (a-tocopherol) in skin and
demonstrated synergistic photoprotection (Lin et al, 2003).
In this study, we use the same model to evaluate topical
a-lipoic acid formulations. The experimental design has
previously been published in detail (Lin et al, 2003). Exper-
iments were performed on weanling white Yorkshire pigs in
accord with the guidelines prepared by the Committee on
Care and Use of Laboratory Animals of the Institute of Lab-
oratory Resources, National Research Council (National In-
stitutes of Health, publication no. 86-23, revised 1996). Five
percent DL-a-lipoic acid (Pharmline, Florida, New York) was
dissolved in 50% ethanol. A commercial formulation con-
taining 15% L-ascorbic acid (vitamin C) and 1% DL-a-to-
copherol (vitamin E) (Primacy CþE, SkinCeuticals, Garland,
Texas) and a commercial formulation of a´-lipoic acid (Face
Firming Activator with DMAE, N.V. Perricone, Meriden,
Connecticut) were purchased and opened immediately prior
to use. Antioxidant solutions (500 mL) were applied to
patches of shaved back skin (7.5  10 cm) daily for 4 days.
A 1000-W solar simulator (Lightning Cure 200, Hamamatsu,
Japan) fitted with a WG295 Schott filter to eliminate wave-
lengths less than 295 nm delivered ultraviolet irradiation to
the skin’s surface through a liquid light guide at an intensity
of 5 mW per cm2 of UVB and about 40 mW per cm2 of UVA
as measured by a radiometer (IL1700, International Light,
Newburyport, Mississippi). MED was determined as the
lowest dose resulting in erythema with perceptible borders
(40 mJ per cm2 of UVB). Each patch was given solar-sim-
ulated irradiation in triplicate from 0.5  to 2.5  MED at
0.5  MED intervals or 1  to 5  MED at 1  MED in-
tervals. Evaluation was carried out 24 hours later. Erythema
was measured by colorimeter evaluation in the ‘‘a’’ mode
(ColorMouse Too, Color Savvy Systems , Springboro, Ohio)
of 8  12-in photographic enlargements of skin. Each spot,
together with adjacent unirradiated skin, was measured in
triplicate. The difference between irradiated and unirradiat-
ed skin determined the erythema measurement. Sunburn
cells were determined in formalin-fixed 8 mm punch biopsy
sections stained with hematoxylin and eosin. When irradi-
ation damage was extensive, the figure 35 sunburn cells per
mm was used as an upper limit. Results are expressed as
mean  SD (n¼ 3). The p-values were calculated by Stu-
dent’s t test. No significant protection could be detected
either by reduction of erythema (Fig 1A) or by sunburn cell
(Fig 1B) analysis when untreated skin was compared to skin
treated by 5% a-lipoic acid or a commercial formulation of
a-lipoic acid. As previously reported, a formulation com-
bining 15% L-ascorbic acid and 1% a-tocopherol provided
meaningful photoprotection against solar-simulated irradia-
tion as revealed by erythema (Fig 2A) or sunburn cells
(Fig 2B). Adding 5% a-lipoic acid to the vitamin C and E so-
lution provided no additional photoprotection (Fig 2A and B).
Although a-lipoic acid has antioxidant properties, its po-
tential as an antioxidant has been thought to depend on
reduction to the more potent dihydrolipoic acid. Although
small amounts of dihydrolipoic acid have been measured in
murine skin following topical application of a-lipoic acid
(Podda et al, 1996), this reaction is very inefficient. Reduc-
tion of a-lipoic acid to dihydrolipoic acid can be achieved
with the mitochondrial enzyme dihydrolipoamide dehydro-
genase, but it is not clear whether free a-lipoic acid has
ready access to the mitochondrial compartment (Biewenga
et al, 1996). Glutathione reductase also can carry out the
reduction, but the rate of the reaction is slow (Pick et al,
1995). Several studies have shown that the reaction rate
constant of dihydrolipoic acid with reactive oxygen species
is slower than that of a-lipoic acid (Bisby and Parker, 1998;
Lu and Liu, 2002; Trujillo and Radi, 2002). Moreover, di-
hydrolipoic acid may be pro-oxidant (Scott et al, 1994).
Once a-lipoic acid is oxidized after reaction with a free
radical, its one-electron oxidation product is strongly pro-
oxidant potentially causing free radical damage to cellular
and tissue components(Lu and Liu, 2002). In contrast, for
example, ascorbyl radical has a relatively low pro-oxidant
potential (De Tullio and Arrigoni, 2004). In fact, it prefers to
react with itself and disproportionate rather than attacking
other substrates. It is not clear whether free a-lipoic acid
provides much physiologic antioxidant activity. In mi-
tochondria it is covalently attached to mitochondrial en-
zymes through lysyl residues. Although available in the diet
in tissues with high metabolic activity (e.g., heart), proteoly-
tic enzymes do not effectively cleave the linkage between
a-lipoic acid and lysine (Biewenga et al, 1997). Free a-lipoic
acid is not normally detected in plasma (Hermann et al,
1996) or in skin (Podda et al, 1994). Following oral or1This work was done in Durham, North Carolina, USA.
Copyright r 2004 by The Society for Investigative Dermatology, Inc.
996
parenteral infusion, it remains in plasma only about 30
minutes and is cleared by liver during first pass (Hermann
et al, 1996; Teichert et al, 2003). Similar rapid clearance may
also occur after percutaneous absorption.
In summary, we have tested a-lipoic acid at high doses
topically to skin to determine if it provides photoprotection
against solar-simulated radiation. We were unable to detect
protection using a-lipoic acid alone or together with vita-
mins C and E. In addition, a commercial formulation of
a-lipoic acid provided no protection. Although we are un-
able to explain this lack of effect, it seems reasonable that
a-lipoic acid absorbs ultraviolet light in the UVA spectrum—
it has an absorption spectrum at 330 nm (Matsugo et al,
1996)—and is oxidized to its free radical and subsequently
destroyed (Podda et al, 1997). Conversion to dihydrolipoic
acid is inefficient resulting in little interaction with vitamins C
and E to augment their photoprotection.
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Figure 2
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